Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Search for FDA Guidance Documents

Search for FDA Guidance Documents

                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents Home
          Regulatory Information
          Search for FDA Guidance Documents
          Guidance for Industry: Food Additive Petition Expedited ReviewSearch for FDA Guidance Documents GUIDANCE DOCUMENT
	Guidance for Industry: Food Additive Petition Expedited Review
					
		
		October 2010


	 

    Final

	  
	  
	Share
    Post
    Linkedin

    Email
    PrintDocket Number:
		    FDA-2020-D-1918
	    	    		    Issued by:
		    Guidance Issuing Office
          Center for Food Safety and Applied Nutrition


*This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations.*

I. Introduction

This guidance is intended for industry and describes the criteria and procedures under which expedited review will be conducted for certain food additive petitions that are expected to have a significant impact on food safety. This guidance is a revision of the January 4, 1999 guidance titled "Guidance for Industry and Center for Food Safety and Applied Nutrition Staff: Food Additive Petition Expedited Review."

FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.

II. Expedited Review

FDA believes it is in the interest of enhanced food safety to review petitions for certain food additive uses in an expedited manner. Expedited review will generally be considered when an additive is intended to decrease the incidence of food-borne illness. For example, FDA has received petitions for the use of sources of radiation and for chemicals such as chlorine dioxide to reduce the levels of pathogenic organisms in various foods.

Designating food additive petitions for expedited review means that the food additive petition would be reviewed ahead of other pending food additive petitions, *i.e.*, the petition will be placed at the beginning of the appropriate review queues.

Petitions under expedited review would be subject to all other controls and requirements applicable to comparable petitions in the standard review process. Accordingly, valid scientific evidence, as defined by Title 21 of the Code of Federal Regulations, section 171.1, would be required to support an expedited review petition. Likewise, the standard for safety and data presentation would remain unchanged.

Criteria

In order to provide more rapid approval of food additives that are intended to significantly increase the safety of the food supply, FDA will consider expedited review of petitions for additives that meet the following criteria:

Use of the additive as proposed is intended to significantly decrease exposure to human pathogens (*e.g.*, *E. coli*, *Salmonella*, *Campylobacter*, *Cyclospora*, or *Listeria*) or their toxins in/on food.
	The petition is complete in terms of 21 CFR 171.1 and appears to contain sufficient data and information to support a decision whether to approve the additive, *i.e.*, the petition satisfies the criteria for filing.Procedures

**Identification of Applications for Expedited Review**. As food additive petitions are received by FDA, the Office Director, in consultation with the appropriate Division Director, will identify those petitions that meet the criteria for expedited review. In addition, if a sponsor believes that their petition meets the criteria for expedited review listed above, they should identify it as such along with their reasoning when the petition is submitted to FDA.
	**Determination of Expedited Review**. The decision to expedite review will be made at the time a petition is filed. FDA may also designate a petition already under review for expedited review if it determines, during the review, that the petition qualifies for expedited review. Consumer Safety Officers and review staff should take the opportunity during the post-filing review and decision period of petitions not already undergoing expedited review to determine whether these petitions should be designated for expedited review.
	**Documentation and Processing**. After the determination to expedite review has been made, the Consumer Safety Officer assigned to the petition will prepare a written memorandum to the administrative record that identifies, using the criteria outlined above, the reasons for designating the petition for expedited review. FDA will notify the petitioner in writing of the expedited review designation. FDA also will notify the petitioner when any food additive petition is subsequently removed from expedited review designation.
	**Resource Management**. It will be the responsibility of the Director of the reviewing Division to ensure that an expedited review petition is reviewed in the most efficient manner, tracked as an expedited review, and completed within established time frames. FDA recognizes that implementation of this policy may affect other review work of FDA because additional resources may be required to review petitions designated for expedited review. All of the following resource issues should be considered as part of the implementation of the expedited review process:
	a shift in the workload within the affected reviewing Division may be necessary;
		scientists from other Divisions may be called upon to provide support to those areas where the standard review queue would otherwise be significantly affected by the needed redistribution of the workload; and
		review of the standard (*i.e.* non-expedited) petitions in reviewing Divisions may occur after the review of petitions designated for expedited review.
	**Review of petition**. Except for the position in the review queue, there will be no change in the procedures for review of petitions designated for expedited review.
	**Monitoring**. The Director of the reviewing division will periodically review, approximately every 90 days, the status of petitions designated for expedited review and will evaluate the effect of the expedited review both on expedited petitions and standard petitions in the review queue to determine whether the allocation of review personnel is appropriate.
	**Public Disclosure.** The fact that a petition is being reviewed under these expedited procedures is information that will be publicly disclosed to any interested party. For information about petitions designated for expedited review contact FDA's Office of Food Additive Safety, 5001 Campus Drive, College Park, Maryland, 20740-3835, 240-402-1200.[1] This guidance has been prepared by the Division of Petition Review in the Center for Food Safety and Applied Nutrition at the U.S. Food and Drug Administration.

Related Information

Ingredients, Additives, GRAS & Packaging Guidance Documents & Regulatory InformationSubmit Comments
	   		  			    		Submit Comments Online
					You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
						If unable to submit comments online, please mail written comments to:
						Dockets Management
							Food and Drug Administration
							5630 Fishers Lane, Rm 1061
							Rockville, MD 20852
						All written comments should be identified with this document's docket number: FDA-2020-D-1918.

                                                                                  Content current as of:
      09/20/2018
         
                  
Regulated Product(s)
		 Food & Beverages
			  			     			  						              
			
			
			
			
			
						  Food & Color AdditivesSearch for FDA Guidance Documents

        Search for FDA Guidance Documents

          
                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop